2025-12-13 - Analysis Report
Okay, here's a report analyzing Equinix Inc. (EQIX) based on the provided data, following your instructions:

**1. Return Rate Comparison (vs. S&P 500)**

*   **Ticker:** EQIX
*   **Company Overview:** Equinix Inc. is a global digital infrastructure company that operates data centers and provides interconnection services.
*   **EQIX Cumulative Return:** 29.44%
*   **VOO (S&P 500) Cumulative Return:** 102.37%
*   **Divergence:**
    *   Current: -72.2
    *   Relative Divergence: 0.7

**Analysis:**

EQIX has significantly underperformed the S&P 500 over the period implied by the cumulative return data.  The current divergence is -72.2, indicating a substantial difference in returns. The relative divergence of 0.7 suggests that the current divergence is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta    | Cap(B)  |
|------------|----------|----------|---------|---------|---------|
| 2015-2017  | 37.0%    | 65.9%    | 8.0%    | 0.0     | 45.5    |
| 2016-2018  | -11.0%   | 71.8%    | -26.0%   | -0.0    | 35.4    |
| 2017-2019  | 17.0%    | 71.8%    | -5.0%   | -0.2    | 58.5    |
| 2018-2020  | 24.0%    | 78.9%    | 0.0%    | -0.1    | 71.6    |
| 2019-2021  | 74.0%    | 78.9%    | 27.0%   | 0.2     | 84.8    |
| 2020-2022  | -4.0%    | 79.9%    | -3.0%   | 1.4     | 65.7    |
| 2021-2023  | -22.0%   | 80.2%    | -23.0%   | 2.0     | 80.8    |
| 2022-2024  | -6.0%    | 80.2%    | -26.0%   | 2.1     | 94.6    |
| 2023-2025  | -10.0%   | 81.7%    | -77.0%   | 1.1     | 73.7    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate has fluctuated significantly, showing strong growth in some periods (e.g., 2015-2017, 2019-2021) but declines in others.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant downside risk.  MDD values are very high, ranging from ~66% to 82%, suggest high volatility or exposure to systemic risk.
*   **Alpha:** Alpha is frequently negative, suggesting EQIX has underperformed relative to its risk-adjusted benchmark. The most recent period (2023-2025) shows a particularly large negative alpha of -77.0%.
*   **Beta:**  Beta varies, with some periods showing negative Beta (suggesting EQIX moved inversely to the market) and more recent periods showing a positive Beta (moving in the same direction as the market). The Beta values have increased significantly in recent years (2020-2025), implying a higher correlation and sensitivity to market movements.
*   **Cap(B):** This is the Market Capitalization in Billions. It shows the general size of the company and how that fluctuates over time.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 734.40
*   **Last-market:** price: 750.32, previousClose: 754.13, change: -0.51
*   **5-day SMA:** 736.53
*   **20-day SMA:** 755.13
*   **60-day SMA:** 790.60

**Analysis:**

The stock price is currently below all three moving averages (5-day, 20-day, and 60-day). This suggests a short-term, medium-term, and potentially long-term downward trend.  The price is decreasing by -0.51, indicating negative growth.
The fact that the 5-day SMA is closest to the current price suggests a possible short-term stabilization, but the longer-term SMAs indicate continued downward pressure.

**3. RSI, PPO, and Divergence Analysis**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 34.62
*   **PPO:** -0.0422
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03)
*   **Recent Relative Divergence Change (20 days):** 0.7 (+) 단기상승 (Short-term increase)
*   **Expected Return (%):** -1683.9%

**Analysis:**

*   **MRI:** The Medium Investment recommendation suggests a moderate level of risk and potential reward, but this seems at odds with other indicators.
*   **RSI:** The RSI of 34.62 indicates that the stock is nearing oversold conditions (typically below 30), which *could* signal a potential buying opportunity or a short-term bounce.
*   **PPO:** The negative PPO (-0.0422) confirms the downward trend, as it measures the distance between two moving averages as a percentage.
*   **Hybrid Signal:** The hybrid signal, though recommending a 100% buy with cash, has a MRI of 0.9 which contradicts the individual MRI of 0.8.
*   **Recent Relative Divergence Change:** The positive divergence change over the last 20 days is interesting as it goes against other indicators and may suggest a short-term correction of the recent decrease.
*   **Expected Return:** The significantly negative expected return (-1683.9%) is extremely concerning and points to major issues or a flawed calculation. This would strongly advise against a long-term investment at this point.

**4. Recent News & Significant Events**

*   **[2025-11-28] Why Is Equinix (EQIX) Down 9.9% Since Last Earnings Report?** - Indicates potential concerns related to recent financial performance.
*   **[2025-12-11] Ditch Digital Realty For Equinix (NASDAQ:EQIX)** - Suggests a possible preference for EQIX over a competitor.
*   **[2025-12-12] Canada Pension Plan Investment Board Has $876.94 Million Stock Position in Equinix, Inc. $EQIX** - A large institutional investor holding a significant position could be a positive sign, but needs further investigation to understand their investment strategy.
*   **[2025-12-10] Forget Iren's Explosive Growth: Buy This Better Long-Term Stock Instead** - Another article suggesting EQIX as a potentially better long-term investment option compared to another company.
*   **[2025-12-12] Equinix (EQIX) Initiated with a Buy at Citi** - A positive signal from a major financial institution.
*   **[2025-12-11] How Investors Are Reacting To Equinix (EQIX) CFO Transition and New Sustainability Leadership Recognition** - Potential uncertainties surrounding CFO transition and positive reactions to ESG efforts.

**Analysis:**

The news is mixed. There are articles pointing to underperformance since the last earnings report and CFO transition uncertainties which are obviously negative, but other articles highlight positive analyst ratings ("Buy" from Citi), suggest EQIX as a better long-term investment than competitors, and mention a large institutional holding. The differing opinions highlight the need for further investigation.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.59)
*   **Opinions:** 25
*   **Target Price (avg/high/low):** 965.28 / 1200.00 / 804.00

**Analysis:**

The analyst consensus is "Buy" with a relatively low mean score (1.59), indicating a generally positive outlook. The average target price of $965.28 is significantly higher than the current price, suggesting potential upside. However, the range between the high and low target prices ($1200 and $804, respectively) shows considerable disagreement among analysts.  Without knowing the previous rating changes, it's hard to know if sentiment is improving or declining.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출       |
|--------------|------|------------|
| 2025-10-29   | 3.82 | 2.32 B$    |
| 2025-07-30   | 3.76 | 2.26 B$    |
| 2025-04-30   | 3.52 | 2.23 B$    |
| 2024-10-30   | 3.11 | 2.20 B$    |
| 2025-10-29   | 3.11 | 2.20 B$    |

**Analysis:**

EPS and revenue generally show a positive trend. EPS has increased from $3.11 to $3.82 and revenue has increased from $2.20B to $2.32B. This indicates potential growth and improved profitability. One potential error exists as 2024-10-30 and 2025-10-29 share the same values.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $2.32B  | 50.69%        |
| 2025-06-30   | $2.26B  | 51.95%        |
| 2025-03-31   | $2.23B  | 51.28%        |
| 2024-12-31   | $2.26B  | 47.10%        |
| 2024-09-30   | $2.20B  | 50.11%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $14.16B   | 2.64%  |
| 2025-06-30   | $14.08B   | 2.61%  |
| 2025-03-31   | $13.89B   | 2.47%  |
| 2024-12-31   | $13.53B   | -0.10% |
| 2024-09-30   | $13.59B   | 2.19%  |

**Analysis:**

*   **Revenue and Profitability:** Revenue is showing a steady increase, indicating growth. Profit margin has also remained relatively stable around 50%, except for a dip in 2024-12-31. This suggests efficient operations.
*   **Capital and Profitability:** Equity has been increasing consistently, indicating a strengthening financial position. ROE (Return on Equity) is positive and generally increasing, except for a negative ROE in 2024-12-31. This suggests better utilization of shareholder equity to generate profits.

**7. Comprehensive Analysis (Summary)**

Equinix (EQIX) presents a mixed investment picture. While recent earnings and financial data show positive trends in revenue, profitability, and equity, the stock has significantly underperformed the S&P 500, with a large negative divergence. Technical indicators show a downward trend, with the price below key moving averages, although the RSI suggests the stock may be approaching oversold conditions.

Analyst opinions are generally positive ("Buy" consensus), with a significantly higher average target price, but the range of target prices indicates some uncertainty. Recent news highlights both positive and negative aspects, including analyst upgrades, potential CFO transition concerns, and an article explaining the stock decline since the last earnings report.

The negative expected return figure is highly concerning and requires verification. If accurate, it indicates significant risks associated with a long-term investment at the current price.

Overall, the information suggests a cautious approach. While some indicators point to potential upside, the underperformance, negative expected return, and mixed news suggest that further research and due diligence are essential before making an investment decision. One should also determine what caused the negative ROE in Q4 2024.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.